Bluejay - BJDX Net earnings per share for the last four quarters

Bluejay Diagnostics Corp (BJDX) - corporate logo

In the short term, Bluejay Diagnostics (BJDX) faces pressure from global laboratories and low-cost Asian counterparts, yet its long-term potential relies on the implementation of the Symphony system and FDA approval. Growing clinic demand for rapid sepsis tests supports the momentum, while the 12-month YoY EPS growth rates visualize the current impulse. The value of 94.30 represents the latest reading for this indicator.

BJDX bluejaydx.com: Net earnings per share (EPS TTM) in the range 02/11/2024 - 11/12/2026

Financial and market metric breakdowns for Bluejay (BJDX)

- market price and analyst price targets:
Market Chart bluejaydx.com|BJDX - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization Bluejay Diagnostics Inc|BJDX - Total Company Value
- book value of equity indicators:
Net Assets per Share Bluejay Diagnostics|BJDX - Book Capitalization|Market Value to Book Value Ratio bluejaydx.com|BJDX - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Bluejay Diagnostics|BJDX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Bluejay Diagnostics Corp|BJDX - Company Aggregate Debts|Debts to Book Value Bluejay Diagnostics Inc|BJDX - Company Long-Term Debt|Amount of Current Liabilities Bluejay Diagnostics|Quick Ratio bluejaydx.com
- business earnings and investment ratios data:
BJDX - Net Income|Expected Net Profit Bluejay Diagnostics|BJDX - Price to Earnings Ratio|Future Price to Earnings Multiple Bluejay Diagnostics Inc|BJDX - PEG Multiple|Enterprise Value to Operating Income Before Depreciation Bluejay Diagnostics Inc|BJDX - Operating profit EBITDA|Net earnings per share for the last four quarters Bluejay Diagnostics|BJDX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth bluejaydx.com|BJDX - Earnings growth in current year|Net earnings per one share growth forecast for next year Bluejay Diagnostics
Fundamental company valuation:BJDX, bluejaydx.com
Flagship merchandise of Bluejay

This indicator measures the dynamics of net income per share over a rolling year, reflecting the efficiency of value generation for shareholders. The current value of 94.30 allows for an assessment of the business scaling pace. By analyzing the annual EPS TTM growth rate, an investor can see the impact of the Symphony platform implementation and the sale of consumables in US clinics. Stable growth of this metric confirms the successful completion of FDA certification. This indicates that Bluejay Diagnostics (BJDX) is transitioning toward sustainable operating profit.

Competitor analysis

Net earnings per share for the last four quarters agilent.com A|DGX: Net earnings per share (EPS TTM)|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cologuard|Revvity Corp (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Earnings per share for the last twelve months NNNN (anbio.com)|Earnings per share for the last twelve months Sotera Health SHC|Quidel Corporation - Earnings per share for the last twelve months|OPK: Net earnings per share for the last 12 months|CDNA - Net earnings per share (EPS TTM)|MRVI: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months fulgentgenetics.com (FLGT)|Earnings per share for the last twelve months Standard BioTools|CTKB (Cytek Biosciences Inc) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) OSUR|Net earnings per share (EPS TTM) exagen.com (XGN)|MDxHealth SA - Net earnings per share for the last 12 months|luciddx.com (LUCD) - Net earnings per one share for the last twelve months|PRE: Net earnings per share for the last 12 months|Earnings per share for the trailing year IMDX (Insight Molecular Diagnostics)|TRIB: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months PRPH|AIMD (Ainos, Inc.) - Net earnings per share (EPS TTM)|codiagnostics.com (CODX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HSCS|Net earnings per share (EPS TTM) Biomerica Inc. (BMRA)|Net earnings per share (EPS TTM) CDIO (Cardio Diagnostics Holdings)|Net earnings per share for the trailing year Onconetix Corporation|VRAX - Earnings per share for the last twelve months|AWH (aspirawh.com) - Earnings per share for the last 12 months|Accelerate Diagnostics, Inc. (AXDX) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months centogene.com (CNTG)|Earnings per share for the last twelve months Enzo Biochem Inc.|Fresh2 (FRES) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months GENE (Genetic Technologies)|Earnings per share for the last four quarters ME|Net earnings per share (EPS TTM) PMD (Psychemedics Corporation)